Prevalence of aspirin resistance in patients with an evolving acute myocardial infarction

This publication has 23 references indexed in Scilit:

• A Critical Appraisal of the Phenomenon of Aspirin Resistance
  Cardiology, 2005
• Aspirin resistance:a new independent predictor of vascular events?**Editorials published in the Journal of the American College of Cardiologyreflect the views of the authors and do no necessarily represent the views of JACCor the American College of Cardiology.
  Journal of the American College of Cardiology, 2003
• Cyclooxygenase-2 expression is induced during human megakaryopoiesis and characterizes newly formed platelets
  Proceedings of the National Academy of Sciences, 2002
• Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients
  BMJ, 2002
• Platelet function analyzer (PFA-100): A tool to quantify congenital or acquired platelet dysfunction
  Journal of Laboratory and Clinical Medicine, 2001
• Myocardial infarction redefined—A consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction
  European Heart Journal, 2000
• Prior aspirin use predicts worse outcomes in patients with non–ST-elevation acute coronary syndromes11This study was sponsored by COR Therapeutics Inc., South San Francisco, California; and Schering-Plough Research Institute, Kenilworth, New Jersey.
  The American Journal of Cardiology, 1999
• One hundred years of aspirin
  The Lancet, 1997
• Description of an In Vitro Platelet Function Analyzer-PFA-100™
  Seminars in Thrombosis and Hemostasis, 1995
• Tobit models: A survey
  Journal of Econometrics, 1984